HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Expression of primitive stem cell antigens on the blast cells of patients with chronic myeloid leukemia].

Abstract
The review presents the data available in the literature on an immunological phenotype of early precursors of human hemopoietic cells. Due to advances in hybrid technology, a great lot of monoclonal antibodies suitable for investigations of precursors of hemopoietic cells, including those of a stem cell have been designed. The review gives the basic characteristics of the antigens CD34, CD33, CD7, Thy-1, HLA-DR, and nonstrain-limited antigens expressed on the hemopoietic precursors and provides data on the expression of these antigens on the blast cells of patients with chronic myeloid leukemia (CML). It also discusses whether to identify immunological subvariants of the blast crisis of CML is expedient.
AuthorsA Iu Baryshnikov
JournalVestnik Rossiiskoi akademii meditsinskikh nauk (Vestn Ross Akad Med Nauk) Issue 3 Pg. 9-13 ( 1996) ISSN: 0869-6047 [Print] Russia (Federation)
Vernacular TitleEkspressiia antigenov primitivnoĭ stvolovoĭ kletki na blastnykh kletkakh bol'nykh khronicheskim mieloidnym leĭkozom.
PMID8672965 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, CD34
  • Antigens, CD7
  • HLA-DR Antigens
Topics
  • Antibodies, Monoclonal (immunology)
  • Antigens, CD (analysis)
  • Antigens, CD34 (analysis)
  • Antigens, CD7 (analysis)
  • Blast Crisis (immunology)
  • HLA-DR Antigens (analysis)
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (immunology, pathology)
  • Phenotype
  • Stem Cells (immunology)
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: